Patent · US Active

Medical device for administering anti-IL-23 antibodies

US12129293B2 · kind B2 · utility

0Cited by
24References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2021
Grant dateOct 29, 2024
Priority date
Expiry dateJun 30, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.